Uva-dare (digital Academic Repository) Tissue Factor Pathway Inhibitor Does Not Influence Inflammatory Pathways during Human Endotoxemia

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.

  2000cited by this paper
• Coagulation abnormalities in sepsis: relation with inflammatory responses

  2000cited by this paper
• Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?

  2000cited by this paper
• New Potential Therapeutic Modalities: aPC

  1999cited by this paper
• Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation.

  1998cited by this paper
• RANDOMIZED, BLINDED, PLACEBO‐CONTROLLED TRIAL OF TISSUE FACTOR PATHWAY INHIBITOR IN PORCINE SEPTIC SHOCK

  1998cited by this paper
• Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells.

  1998cited by this paper
• Lipopolysaccharide toxicity-regulating proteins in bacteremia.

  1995cited by this paper
• Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.

  1994cited by this paper
• Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.

  1993cited by this paper
• E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro.

  1992cited by this paper
• Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.

  1992cited by this paper
• Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.

  1991cited by this paper
• Enzyme immunoassay for factor VIII-related antigen.

  1982cited by this paper

• Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis

  2020cites this paper
• Human lipopolysaccharide models provide mechanistic and therapeutic insights into systemic and pulmonary inflammation

  2020cites this paper
• Enoxaparin pretreatment effect on local and systemic inflammation biomarkers in the animal burn model

  2018cites this paper
• Nebulized Recombinant Human Tissue Factor Pathway Inhibitor Attenuates Coagulation and Exerts Modest Anti-inflammatory Effects in Rat Models of Lung Injury

  2017cites this paper
• Haemostatic factors do not account for worse outcomes from ischaemic stroke in patients with higher C-reactive protein concentrations

  2017cites this paper
• Sepsis-Associated Coagulopathy

  2016cites this paper
• The tissue factor pathway in pneumonia

  2015cites this paper
• Nebulized recombinant human Tissue Factor Pathway Inhibitor attenuates coagulation and inflammation in rat models of direct and indirect lung injury

  2015cites this paper
• Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man.

  2013cites this paper
• Coordinated release of tissue factor and tissue factor pathway inhibitor in VLBW infants

  2013cites this paper
• Sepsis, coagulation and anticoagulants.

  2010cites this paper
• Blood coagulation as an intrinsic pathway for proinflammation: a mini review.

  2010cites this paper
• Coagulation disorders in patients with severe leptospirosis are associated with severe bleeding and mortality

  2010cites this paper
• Scientific and clinical challenges in sepsis.

  2009cites this paper
• factor-factor Vil a pathway in murinee pneumococcal pneumonia

  2007cites this paper
• Review: From therapy to experimental model: a hundred years of endotoxin administration to human subjects

  2007cites this paper
• Endothelial cells as active participants in veterinary infections and inflammatory disorders

  2007cites this paper
• Pharmacological Inhibition of Tissue Factor

  2006cites this paper
• Tissue factor upregulation drives a thrombosis–inflammation circuit in relation to cardiovascular complications

  2006cites this paper
• Activated protein C and sepsis.

  2006cites this paper
• Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia*

  2006cites this paper
• Do coagulation abnormalities contribute to sepsis associated organ failure?

  2006cites this paper
• Tissue factor mediates inflammation.

  2005cites this paper
• Disseminated intravascular coagulation in sepsis.

  2005cites this paper
• HUMAN ENDOTOXEMIA: A MODEL FOR MECHANISTIC INSIGHT AND THERAPEUTIC TARGETING

  2005cites this paper
• Inflammation, blood pressure, and stroke: an opportunity to target primary prevention?

  2005cites this paper
• Blood coagulation factors as inflammatory mediators.

  2005cites this paper
• Tissue Factor Pathway Inhibitor and Anitithrombin Trial Results

  2005cites this paper
• Tissue factor pathway inhibitor in thrombosis and beyond.

  2004cites this paper
• Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin‐10 response in human endotoxemia

  2004cites this paper
• Reduction in arthritis severity and modulation of immune function in tissue factor cytoplasmic domain mutant mice.

  2004cites this paper
• Tissue factor: (patho)physiology and cellular biology

  2004cites this paper
• A protein C deficiency exacerbates inflammatory and hypotensive responses in mice during polymicrobial sepsis in a cecal ligation and puncture model.

  2004cites this paper
• Coagulation in sepsis

  2004cites this paper
• Recent developments in the treatment of sepsis

  2003cites this paper
• A META‐ANALYSIS OF CONTROLLED TRIALS OF ANTICOAGULANT THERAPIES IN PATIENTS WITH SEPSIS

  2003cites this paper
• Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia

  2003cites this paper
• Inflammation and the coagulation system.

  2002cites this paper
• New concepts in sepsis

  2002cites this paper
• Evolving role of tissue factor and its pathway inhibitor

  2002cites this paper
• Adult Respiratory Distress Syndrome

  2002cites this paper
• Pharmacodynamics of active site‐inhibited factor VIIa in endotoxin‐induced coagulation in humans

  2002cites this paper
• Effect of factor X inhibition on coagulation activation and cytokine induction in human systemic inflammation.

  2002cites this paper
• Coagulation and Fibrinolysis in Diabetes

  2002cites this paper
• Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders

  2001cites this paper